Cited by 364Cannabis and Cannabinoid ResearchMedicinal Plant Extracts EffectsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Effects of ipsapirone and cannabidiol on human experimental anxiety

Zuardi, A. W., Cosme, R. A., Graeff, F. G., Guimarães, F. S.·1993·Journal of Psychopharmacology

DOI 10.1177/026988119300700112

Open this paper in CoChat — free account

Abstract

The effects of ipsapirone and cannabidiol (CBD) on healthy volunteers submitted to a simulated public speaking (SPS) test were compared with those of the anxiolytic benzodiazepine diazepam and placebo. Four independent groups of 10 subjects received, under a double-blind design, placebo or one of the following drugs: CBD (300 mg), diazepam (10 mg) or ipsapirone (5 mg). Subjective anxiety was evaluated through the Visual Analogue Mood Scale (VAMS) and the State-trait Anxiety Inventory (STAI). The VAMS anxiety factor showed that ipsapirone attenuated SPS-induced anxiety while CBD decreased anxiety after the SPS test. Diazepam, on the other hand, was anxiolytic before and after the SPS test, but had no effect on the increase in anxiety induced by the speech test. Only ipsapirone attenuated the increase in systolic blood pressure induced by the test. Significant sedative effects were only observed with diazepam. The results suggest that ipsapirone and CBD have anxiolytic properties in human volunteers submitted to a stressful situation.

Integrity signals

Registry

Crossref · 10.1177/026988119300700112

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
(1970) · Cited by 24,983
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Manual for the Wechsler Adult Intelligence Scale.
Wechsler, D. (1955) · Psychological Corp. eBooks · Cited by 4,941
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
The development of a scale to measure fear
Geer, J. H. (1965) · Behaviour Research and Therapy · doi:10.1016/0005-7967(65)90040-9 · Cited by 777
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R. J., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 570
Pharmacology of Marihuana
Pertwee, R. G. (1977) · Neuroscience · doi:10.1016/0306-4522(77)90080-x · Cited by 384
The action of sedatives on brain stem oculomotor systems in man
Norris, H. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90039-6 · Cited by 384

Show all 39 references

Research works printed but not linked: 10

Biaggio A M B, 1976, Cross-cultural research on anxiety., 29
Critchley M A E, 1987, Br J Pharmacol, 92, 660
Geer J H, 1965, Behav Res Ther, 193, 785
Gregg J M, 1976, J Oral Surg, 34, 301
Guimarães F S, 1989, Brazilian J Med Biol Res, 22, 1083
Higgins G A, 1987, Br J Pharmacol, 92, 658P
Kuemmel B, 1988, Psychopharmacology, 96, 353, 10.1007/BF00216061 · DOI
Norusis M J, 1988, SPSS/PC + advanced stataistics V. 2.0
Zuardi A W, 1981, J Brasileiro Psiquiatr, 131, 403
Zuardi A W, 1983, Ar Biol Technol, 26, 391

Sorted by citations

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771
Cannabidiol as a Potential Treatment for Anxiety Disorders
Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 752
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Safety and side effects of cannabidiol, a Cannabis sativa constituent
Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report
Crippa, J. A. S., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., Simões, M. V., Bhattacharyya, S., Fusar-Poli, P., Atakan, Z., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379283 · Cited by 535
Cannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 530
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475
Self-citation
Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465
Self-citation
Cannabidiol, neuroprotection and neuropsychiatric disorders
Campos, A. C., Fogaça, M. V., Sonego, A. B., & Guimarães, F. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.033 · Cited by 446
Cannabidiol in Anxiety and Sleep: A Large Case Series
Shannon, S. M., Lewis, N., Lee, H. J., & Hughes, S. (2019) · The Permanente Journal · doi:10.7812/tpp/18-041 · Cited by 467
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Zuardi, A. W. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000300015 · Cited by 421
Cannabis and anxiety: a critical review of the evidence
Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1048 · Cited by 509
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 415
Cannabis and adolescent brain development.
Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Hurd, Y. L., Spriggs, S. A., Alishayev, J., Winkel, G. H., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. A. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101191 · Cited by 344
Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age
Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308
Effects of cannabidiol (CBD) on regional cerebral blood flow
Crippa, J. A. D. S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E. C., McGuire, P. K., & Busatto, G. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300340 · Cited by 307
Cannabidiol: pharmacology and therapeutic targets
Britch, S. C., Babalonis, S., & Walsh, S. L. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05712-8 · Cited by 307
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306
Role of the amygdala and periaqueductal gray in anxiety and panic.
Graeff, F. G., Silveira, M. C. L., Nogueira, R. L., Audi, E. A., & Oliveira, R. M. W. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90097-a · Cited by 301
Self-citation
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
Martín‐Santos, R., Crippa, J. A. S., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., Allen, P., Seal, M. L., Langohr, K., Farré, M., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884780 · Cited by 298
Immune Responses Regulated by Cannabidiol
Nichols, J. M., & Kaplan, B. L. F. (2019) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0073 · Cited by 308
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13710 · Cited by 315
Medical Use of Cannabinoids
Fraguas‐Sánchez, A. I., & Torres‐Suárez, A. I. (2018) · Drugs · doi:10.1007/s40265-018-0996-1 · Cited by 287
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial
Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3947 · Cited by 266
The elevated T-maze: A new animal model of anxiety and memory
Viana, M. D. B., Tomaz, C. A. B., & Graeff, F. G. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90067-1 · Cited by 265
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Zuardi, A. W., Rodrigues, N. P., Silva, A. L., Bernardo, S. A., Hallak, J. E. C., Guimarães, F. S., & Crippa, J. A. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00259 · Cited by 294
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
White, C. M. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1387 · Cited by 258
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
Niesink, R. J. M., & van Laar, M. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00130 · Cited by 253
The endocannabinoid system as a target for novel anxiolytic drugs
Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233
Cannabis and psychiatric disorders: it is not only addiction
Leweke, F. M., & Koethe, D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00106.x · Cited by 213
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Linares, I. M., Zuardi, A. W., Pereira, L. C., Queiroz, R. H., Mechoulam, R., Guimarães, F. S., & Crippa, J. A. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-0015 · Cited by 241
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
Scuderi, C., Filippis, D. D., Iuvone, T., Blasio, A., Steardo, A., & Esposito, G. (2008) · Phytotherapy Research · doi:10.1002/ptr.2625 · Cited by 217
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Haney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G., Gray, K. M., McRae-Clark, A., Lofwall, M. R., Sparenborg, S., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.367 · Cited by 206
Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
Jiang, R., Yamaori, S., Okamoto, Y., Yamamoto, I., & Watanabe, K. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rg-129 · Cited by 199
Cannabidiol in Humans—The Quest for Therapeutic Targets
Zhornitsky, S., & Potvin, S. (2012) · Pharmaceuticals · doi:10.3390/ph5050529 · Cited by 205
Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders
Masataka, N. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.02466 · Cited by 157
A BIOPSYCHOSOCIAL MODEL OF SOCIAL ANXIETY AND SUBSTANCE USE: Review: Biopsychosocial Model of SAD-SUD Comorbidity
Buckner, J. D., Heimberg, R. G., Ecker, A. H., & Vinci, C. (2013) · Depression and Anxiety · doi:10.1002/da.22032 · Cited by 181
Medicinal plants with potential anti-arthritic activity:
Choudhary, M., Kumar, V., Malhotra, H., & Singh, S. (2015) · Journal of Intercultural Ethnopharmacology · doi:10.5455/jice.20150313021918 · Cited by 185
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2036-z · Cited by 174
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Bonaccorso, S., Ricciardi, A., Zangani, C., Chiappini, S., & Schifano, F. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.002 · Cited by 180
Anxiolytic-like effect of oxytocin in the simulated public speaking test
de Oliveira, D. C., Zuardi, A. W., Graeff, F. G., Queiroz, R. H., & Crippa, J. A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111400642 · Cited by 154
Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series
Elms, L., Shannon, S. M., Hughes, S., & Lewis, N. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0437 · Cited by 156
Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence
Sarris, J. J., McIntyre, E., & Camfield, D. (2013) · CNS Drugs · doi:10.1007/s40263-013-0059-9 · Cited by 157
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
Schier, A. R. D. M., Ribeiro, N. P. D. O., Silva, A. C. D. O. E., Hallak, J. E. C., Crippa, J. A. S., Nardi, A. E., & Zuardi, A. W. (2012) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462012000500008 · Cited by 162
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience
Fogaça, M. V., Reis, F. M. C. V., Campos, A. C., & Guimarães, F. S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.012 · Cited by 153
The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
Kicman, A., & Toczek, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186740 · Cited by 169
The Endocannabinoid System of Animals
Silver, R. (2019) · Animals · doi:10.3390/ani9090686 · Cited by 171
Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
Moltke, J., & Hindocha, C. (2021) · Journal of Cannabis Research · doi:10.1186/s42238-021-00061-5 · Cited by 162
Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats
Lemos, J. I., Resstel, L. B., & Guimarães, F. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.045 · Cited by 146
Oxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder
Wilkinson, S. T., Stefanovics, E., & Rosenheck, R. A. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09475 · Cited by 145
Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies
Sholler, D. J., Schoene, L., & Spindle, T. R. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00326-8 · Cited by 143
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety‐related and substance abuse disorders
Lee, J. L. C., Bertoglio, L. J., Guimarães, F. S., & Stevenson, C. W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13724 · Cited by 148
Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease
de Faria, S. M., de Morais Fabrício, D., Tumas, V., Castro, P. C., Ponti, M. A., Hallak, J. E., Zuardi, A. W., Crippa, J. A. S., & Chagas, M. H. N. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119895536 · Cited by 140
Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
Freeman, T. P., Morgan, C. J. A., Hindocha, C., Schäfer, G., Das, R., & Curran, H. V. (2014) · Addiction · doi:10.1111/add.12634 · Cited by 140
The acute effects of L‐theanine in comparison with alprazolam on anticipatory anxiety in humans
Lu, K., Gray, M. A., Oliver, C., Liley, D. T., Harrison, B. J., Bartholomeusz, C. F., Phan, K. L., & Nathan, P. J. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.611 · Cited by 139
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors
Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
Colizzi, M., & Bhattacharyya, S. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0142-2 · Cited by 138
Mood, Anxiety, and Serum IGF-1 in Elderly Men Given 24 Weeks of High Resistance Exercise
Cassilhas, R. C., Antunes, H. K. M., Tufik, S., & de Mello, M. T. (2010) · Perceptual and Motor Skills · doi:10.2466/pms.110.1.265-276 · Cited by 146
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
Marco, E. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00063 · Cited by 139
Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
Babalonis, S. L., Haney, M., Malcolm, R. J., Lofwall, M. R., Votaw, V. R., Sparenborg, S., & WALSH, S. L. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.030 · Cited by 136
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
Schiavon, A. P., Bonato, J. M., Milani, H., Guimarães, F. S., & Weffort de Oliveira, R. M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.017 · Cited by 135
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress
Childs, E., Lutz, J. A., & de Wit, H. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.03.030 · Cited by 138
A naturalistic examination of the perceived effects of cannabis on negative affect
Cuttler, C., Spradlin, A., & McLaughlin, R. J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.054 · Cited by 146
Use of cannabidiol in anxiety and anxiety-related disorders
Skelley, J. W., Deas, C. M., Curren, Z., & Ennis, J. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.11.008 · Cited by 142
Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
Fleury-Teixeira, P., Caixeta, F. V., da Silva, L. C. R., Brasil-Neto, J. P., & Malcher‐Lopes, R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01145 · Cited by 140
Effects of sex hormonal levels and phases of the menstrual cycle in the processing of emotional faces
Guapo, V. G., Graeff, F. G., Zani, A. C. T., Labate, C. M., dos Reis, R. M., & Del‐Ben, C. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.02.007 · Cited by 123
CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults
Wheeler, M., Merten, J. W., Gordon, B. T., & Hamadi, H. Y. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1729201 · Cited by 132
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors
Soares, V. D. P., Campos, A. C., Bortoli, V. C. D., Zangrossi, H., Guimarães, F. S., & Zuardi, A. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.004 · Cited by 112
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm
Uribe-Mariño, A., Biagioni, A. F., Castiblanco-Urbina, M. A., Twardowschy, A., Salgado-Rohner, C. J., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., & Coimbra, N. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.188 · Cited by 111
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
Esposito, G., Filippis, D. D., Cirillo, C., Iuvone, T., Capoccia, E., Scuderi, C., Steardo, A., Cuomo, R., & Steardo, L. (2012) · Phytotherapy Research · doi:10.1002/ptr.4781 · Cited by 105
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report: CBD and cannabis withdrawal
Crippa, J. A. S., Hallak, J. E. C., Machado-de-Sousa, J. P., Queiroz, R. H. C., Bergamaschi, M., Chagas, M. H. N., & Zuardi, A. W. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12018 · Cited by 101
Self-citation
Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
Turna, J., Patterson, B. A., & Ameringen, M. V. (2017) · Depression and Anxiety · doi:10.1002/da.22664 · Cited by 107
Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT 1A receptors
Gomes, F. V., Reis, D. G., Alves, F. H., Corrêa, F. M., Guimarães, F. S., & Resstel, L. B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881110389095 · Cited by 97
Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand
Gulbransen, G., Xu, W., & Arroll, B. (2020) · BJGP Open · doi:10.3399/bjgpopen20x101010 · Cited by 102
A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
Sultan, S. R., Millar, S. A., England, T. J., & O'Sullivan, S. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00081 · Cited by 95
“Overall, there was no relationship between drug dose and the size of the effect on haemodynamics (BP p = 0.81, HR p = 0.97, BF p= 0.97; Figure 6).”
BackgroundInfluential
Cannabidiol (CBD) in Cancer Management
O’Brien, K. (2022) · Cancers · doi:10.3390/cancers14040885 · Cited by 90
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
Appiah‐Kusi, E., Petros, N., Wilson, R. J., Colizzi, M., Bossong, M. G., Valmaggia, L., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05442-6 · Cited by 93
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria
Campos, A. C., Brant, F., de Miranda, A. S., Machado, F. S., & Teixeira, A. L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.051 · Cited by 96
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats
Hsiao, Y.-T., Yi, P.-L., Li, C.-L., & Chang, F.-C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.013 · Cited by 91
Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder
SANTOS, R. G. D., Osório, F. D. L., Rocha, J. M., Rossi, G. N., Bouso, J. C., Rodrigues, L. S., Silveira, G. D. O., Yonamine, M., & Hallak, J. E. C. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001428 · Cited by 97
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
Arnold, J. C., McCartney, D., Suraev, A. S., & McGregor, I. S. (2022) · Clinical and Translational Science · doi:10.1111/cts.13425 · Cited by 90
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
de Almeida, V., Levin, R. R., Peres, F. F., Niigaki, S. T., Calzavara, M. B., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. S., & Abílio, V. C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.024 · Cited by 93
Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Silvestro, S., Schepici, G., Bramanti, P., & Mazzon, E. (2020) · Molecules · doi:10.3390/molecules25215186 · Cited by 93
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze
Guimarães, F. S., Aguiar, J. C. D., Mechoulam, R., & Breuer, A. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90027-2 · Cited by 89
Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala
Réus, G. Z., Stringari, R. B., Ribeiro, K. F., Luft, T., Abelaira, H. M., Fries, G. R., Aguiar, B. W., Kapczinski, F., Hallak, J. E., Zuardi, A. W., et al. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00579.x · Cited by 86
Social anxiety and cannabis use: An analysis from ecological momentary assessment
Buckner, J. D., Crosby, R. D., Wonderlich, S. A., & Schmidt, N. B. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.12.006 · Cited by 86
Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking
Garcia-Leal, C., Parente, A. C. B. V., Del‐Ben, C. M., Guimarães, F. S., Moreira, A. C., Elias, L. L. K., & Graeff, F. G. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.010 · Cited by 87
Uso terapêutico dos canabinoides em psiquiatria
Crippa, J. A. S., Zuardi, A. W., & Hallak, J. E. C. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500009 · Cited by 93
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Wright, M., Ciano, P. D., & Brands, B. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0052 · Cited by 87
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
Valvassori, S. S., Elias, G., de Souza, B., Petronilho, F., Dal-Pizzol, F., Kapczinski, F., Trzesniak, C., Tumas, V., Dursun, S., Nisihara Chagas, M. H., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109106925 · Cited by 80
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
Zlebnik, N. E., & Cheer, J. F. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014038 · Cited by 82
Human Studies of Cannabinoids and Medicinal Cannabis
Robson, P. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_25 · Cited by 78
Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats
Rock, E. M., Limebeer, C. L., Petrie, G. N., Williams, L. A., Mechoulam, R., & Parker, L. A. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4626-5 · Cited by 74
Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice
Flack, N., Colwell, M., Drown, C., & Faulk, C. D. (2021) · Clinical Epigenetics · doi:10.1186/s13148-020-00993-4 · Cited by 72
Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research
McCartney, D., Benson, M. J., Desbrow, B., Irwin, C. G., Suraev, A. S., & McGregor, I. S. (2020) · Sports Medicine - Open · doi:10.1186/s40798-020-00251-0 · Cited by 79
Pharmacology of human experimental anxiety
Graeff, F. G., Parente, A., Del-Ben, C. M., & Guimarães, F. S. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000400003 · Cited by 70
“(31) Clomipramine 25 0 + 0 Guimarães et al.”
The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group
Hundal, H., Lister, R., Evans, N., Antley, A., Englund, A., Murray, R. M., Freeman, D. H., & Morrison, P. D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117737400 · Cited by 70
Current application of cannabidiol (CBD) in the management and treatment of neurological disorders
Fiani, B., Sarhadi, K. J., Soula, M., Zafar, A., & Quadri, S. A. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04514-2 · Cited by 70

Authors: Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S.
Affiliations: Universidade de São Paulo (BR)
ORCID: Zuardi, A. W.
Graeff, F. G.
Venue: Journal of Psychopharmacology
Publisher: SAGE Publications
Published: 1993-01
Volume: 7
Issue: 1_suppl
Pages: 82-88
ISSN: 0269-8811 (ISSN-L)
1461-7285
DOI: 10.1177/026988119300700112
OpenAlex: W1696206979
Cited by: 364
References: 39
Citations by year: 2026: 4 · 2025: 10 · 2024: 33 · 2023: 28 · 2022: 37 · 2021: 28 · 2020: 43 · 2019: 25 · 2018: 11 · 2017: 21 · 2016: 12 · 2015: 12 · 2014: 9 · 2013: 10 · 2012: 17
FWCI: 2.33
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Journal of Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: ipsapirone, cannabidiol, diazepam, anxiety, anxiolytic effects, stress response, blood pressure, sedation, healthy volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of ipsapirone and cannabidiol on human experimental anxiety

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks